Glenmark Pharmaceuticals Limited — Others, 04-08-2025: Trading Window

Glenmark Pharmaceuticals Ltd. has announced a board meeting. A key item on the agenda is the consideration and approval of the financial results for the recent quarter. This upcoming announcement is crucial for shareholders, providing insights into the company's operational and financial performance. Additionally, Glenmark has closed its trading window for directors and designated persons. This measure is a standard practice to prevent insider trading, ensuring equitable information access and market transparency before the official release of the financial figures.